MEDEL ROGER MD
Known title: DirectorCIK: 0001093125
Associated companies
Transaction History
| MD | ▲ Buy | Grant | 8,480 | $0 | 5/12/2022 | View on chart |
| MD | ▼ Sell | Open Market | 40,107 | $1.1M | 1/11/2022 | View on chart |
| MD | ▼ Sell | Open Market | 59,893 | $1.6M | 1/10/2022 | View on chart |
| MD | ▼ Sell | Open Market | 12,639 | $347K | 1/5/2022 | View on chart |
| MD | ▼ Sell | Open Market | 87,361 | $2.4M | 1/4/2022 | View on chart |
| MD | ▼ Sell | Open Market | 6,564 | $178K | 12/31/2021 | View on chart |
| MD | ▼ Sell | Open Market | 45,397 | $1.2M | 12/30/2021 | View on chart |
| MD | ▼ Sell | Open Market | 25,000 | $682K | 12/29/2021 | View on chart |
| MD | ▼ Sell | Open Market | 44,514 | $1.2M | 12/28/2021 | View on chart |
| MD | ▼ Sell | Open Market | 66,868 | $1.8M | 12/27/2021 | View on chart |
| MD | ▼ Sell | Open Market | 10,387 | $301K | 10/28/2021 | View on chart |
| MD | ▼ Sell | Open Market | 1,270 | $37K | 10/4/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
MD mentioned in list of stocks with questionable fundamentals
Pediatrix Medical Group (MD) was recently included in a Yahoo Finance article highlighting three unpopular stocks with questionable fundamentals. This mention draws attention to the company's valuation and financial metrics, placing it in a category that some market observers view with caution. The stock currently trades near its 52-week high range, with an average analyst target price of $26.33.
MD mentioned in list of stocks with questionable fundamentals. Pediatrix Medical Group (MD) was recently included in a Yahoo Finance article highlighting three unpopular stocks with questionable fundamentals. This mention draws attention to the company's valuation and financial metrics, placing it in a category that some market observers view with caution. The stock currently trades near its 52-week high range, with an average analyst target price of $26.33.